Day: August 7, 2024

Declares Dividend of $0.34 per share for Q2 2024; Represents Genco’s 20th Consecutive Quarterly Dividend Totaling $5.915 Per Share NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today reported its financial results for the three months and six months ended June 30, 2024. Second Quarter 2024 and Year-to-Date HighlightsDividend: Declared a $0.34 per share dividend for Q2 202420th consecutive quarterly dividend over the last five years Cumulative dividends of $5.915 per share or 33% of our share price1 Q2 2024 dividend is payable on or about August 26, 2024 to all shareholders of record as of August 19, 2024.Financial performance: Net income of $23.5 million...

CALGARY, Alberta, Aug. 07, 2024 (GLOBE NEWSWIRE) — Wilmington Capital Management Inc. (“Wilmington” or the “Corporation”) reported a net loss for the three months ended June 30, 2024, of ($0.1) million or ($0.01) per share and net income for the six months ended June 30, 2024, of $1.1 million or $0.08 per share. compared to net income of $0.7 million or $0.06 per share and $0.1 million and $0.01 per share for the same periods in 2023. A summary of the Corporation’s activities and the operations of its investees is set out below: OverviewDuring the past 12 months the Corporation has monetized a number of its investments in order to unlock the embedded value, which had been substantially realized, simplify its business, repatriate capital to its shareholders and pursue transactions better suited to a changing economic environment. On...

Dallas, Texas, Aug. 07, 2024 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported net income attributable to NL stockholders of $7.9 million, or $.16 per share, in the second quarter of 2024 compared to a net loss attributable to NL stockholders of $3.1 million, or $.06 per share, in the second quarter of 2023. NL results include an unrealized gain of $.8 million in the second quarter of 2024 related to the change in value of marketable equity securities compared to an unrealized loss of $5.4 million in the second quarter of 2023. For the first six months of 2024, NL reported net income attributable to NL stockholders of $14.7 million, or $.30 per share, compared to a net loss attributable to NL stockholders of $9.8 million, or $.20 per share for the first six months of 2023. NL results include an unrealized gain of...

Announced acquisition of CT-95, a mesothelin x CD3 bispecific antibody Claudio Dansky Ullmann, M.D. named Chief Medical Officer Cash and cash equivalents of $101.5 million as of June 30, 2024 PHILADELPHIA, Aug. 07, 2024 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced its financial results for the second quarter ended June 30, 2024, and reported on recent business highlights. “Context continues to build momentum, and we believe the Company is well positioned to have a successful year,” said Martin Lehr, CEO of Context. “Our team recently initiated our Phase 1 trial for CTIM-76, a Claudin 6 x CD3 bispecific antibody and looks forward to dosing our first patient in the third quarter. In addition, the recent acquisition...

HOUSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) today announced its second quarter 2024 financial results. The earnings release and accompanying financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Thursday, August 8, 2024, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10189702/fca6e74d6e. A recording of the webcast will be posted on the Investor Relations section of the company’s...

Dallas, TX, Aug. 07, 2024 (GLOBE NEWSWIRE) — Kronos Worldwide, Inc. (NYSE:KRO) today reported net income of $19.5 million, or $.17 per share, in the second quarter of 2024 compared to a net loss of $8.2 million, or $.07 per share, in the second quarter of 2023. For the first six months of 2024, Kronos Worldwide reported net income of $27.6 million, or $.24 per share, compared to a net loss of $23.4 million, or $.20 per share, in the first six months of 2023. Net income increased in the 2024 periods as compared to the same periods in 2023 primarily due to higher income from operations as a result of the effects of higher sales and production volumes, lower production costs (primarily energy and raw materials), partially offset by lower average TiO2 selling prices. Our results of operations in the first six months of 2023 were significantly...

Higher Occupancy and Cost Management Initiatives Drive PositiveQuarterly Financial Performance BRENTWOOD, Tenn., Aug. 07, 2024 (GLOBE NEWSWIRE) — CoreCivic, Inc. (NYSE: CXW) (CoreCivic or the Company) announced today its second quarter 2024 financial results.   Financial Highlights – Second Quarter 2024Total revenue of $490.1 millionCoreCivic Safety revenue of $455.4 million CoreCivic Community revenue of $30.3 million CoreCivic Properties revenue of $4.4 millionNet income of $19.0 million; Adjusted Net Income of $21.8 million Diluted earnings per share of $0.17; Adjusted Diluted EPS of $0.20 Normalized FFO per diluted share of $0.42, an increase of 27% Adjusted EBITDA of $83.9 million, an increase of 16%Damon T. Hininger, CoreCivic’s President and Chief Executive Officer, commented, “CoreCivic carried its...